LifePoint Health, Inc. to Post FY2018 Earnings of $4.60 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:LPNT)

LifePoint Health, Inc. (NASDAQ:LPNT) – Investment analysts at Cantor Fitzgerald lowered their FY2018 EPS estimates for shares of LifePoint Health in a research note issued on Tuesday. Cantor Fitzgerald analyst J. France now anticipates that the company will post earnings per share of $4.60 for the year, down from their previous forecast of $4.70.

LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.06. The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a net margin of 2.61% and a return on equity of 7.40%. LifePoint Health’s revenue for the quarter was up .2% on a year-over-year basis. During the same period last year, the company posted $0.69 EPS.

WARNING: “LifePoint Health, Inc. to Post FY2018 Earnings of $4.60 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:LPNT)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/lifepoint-health-inc-to-post-fy2018-earnings-of-4-60-per-share-cantor-fitzgerald-forecasts-nasdaqlpnt-updated.html.

Several other brokerages have also issued reports on LPNT. BidaskClub lowered LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Barclays PLC boosted their price target on LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a research note on Monday, May 1st. Zacks Investment Research raised LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 price target on the stock in a research note on Thursday, July 13th. Morgan Stanley initiated coverage on LifePoint Health in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 price target on the stock. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a research note on Wednesday, July 5th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $66.18.

Shares of LifePoint Health (LPNT) traded down 1.71% during mid-day trading on Wednesday, hitting $57.65. 165,671 shares of the company were exchanged. The firm has a 50 day moving average of $64.19 and a 200 day moving average of $62.87. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95. The company has a market capitalization of $2.31 billion, a price-to-earnings ratio of 12.91 and a beta of 0.86.

In related news, Chairman William F. Carpenter III sold 17,653 shares of the stock in a transaction on Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the completion of the sale, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total value of $5,282,560.05. Following the completion of the sale, the chairman now directly owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The disclosure for this sale can be found here. Insiders sold a total of 102,000 shares of company stock valued at $6,556,824 over the last three months. 7.28% of the stock is currently owned by insiders.

A number of large investors have recently added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares in the last quarter. LS Investment Advisors LLC increased its stake in LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock valued at $120,000 after buying an additional 543 shares in the last quarter. US Bancorp DE increased its stake in LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can increased its stake in LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares in the last quarter. Finally, Teacher Retirement System of Texas acquired a new stake in LifePoint Health during the first quarter valued at approximately $210,000. 99.27% of the stock is owned by institutional investors and hedge funds.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit